Genetic background markedly influences vulnerability of the hippocampal neuronal organization in the "twitcher" mouse model of globoid cell leukodystrophy

Journal of Neuroscience Research

Volumn 77, Issue 4, 2004, Pages 507-516

  Tominaga, Kumiko ^a   Matsuda, Junko ^a   Kido, Makiko ^a   Naito, Etsuo ^a   Yokota, Ichiro ^a   Toida, Kazunori ^a   Ishimura, Kazunori ^a   Suzuki, Kunihiko ^b   Kuroda, Yasuhiro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Hippocampus; Krabbe disease; Lactosylceramide; Neuronal cell death; Sphingolipids

Indexed keywords

GALACTOSYLCERAMIDASE; LACTOSYLCERAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL INFILTRATION; CONTROLLED STUDY; DEMYELINATION; GLOBOID CELL LEUKODYSTROPHY; GRAND MAL SEIZURE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; MUTANT; NERVE CELL NECROSIS; NEUROPATHOLOGY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIPPOCAMPUS; LACTOSYLCERAMIDES; LEUKODYSTROPHY, GLOBOID CELL; MALE; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; MUTATION; NERVE DEGENERATION; NEURONS; PHENOTYPE; SPECIES SPECIFICITY; SPHINGOLIPIDS;

EID: 3442886765     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20190     Document Type: Article

References (41)

1. Abramson MB, Norton WT, Katzman R. 1965. Study of ionic structure in phospholipids by infrared spectra. J Biol Chem 240:2389-2395.
2. Biswas S, Biesiada H, Williams TD, LeVine SM. 2002. Delayed clinical and pathological signs in twitcher (globoid cell leukodystrophy) mice on a C57BL/6 x CAST/Ei background. Neurobiol Dis 10:344-357.
3. Bouvier JD, Seyfried TN. 1990. Ganglioside GM1 elevation in DBA/2 mouse embryos Dev Neurosci 12:126-132.
4. Coeczee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K, Suzuki K, Popko B. 1996. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86:209-219.
5. Duchen LW, Eicher EM, Jacobs JM, Scaravilli F, Teixeira F. 1980. Hereditary leukodystrophy in the mouse: the new mutant twitcher. Brain 103:695-710.
6. Felton J, Meisler M, Paigen K. 1974. A locus determining beta-galactosidase activity in the mouse. J Biol Chem 249:3267-3272.
7. Fujita N, Suzuki K, Vanier MT, Popko B, Maeda N, Klein A, Henseler M, Sandhoff K, Nakayasu H, Suzuki K. 1996. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum Mol Genet 5:711-725.
8. Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ. 1999. Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 2:260-265.
9. Gulbins E, Kolesnick R. 2003. Raft ceramide in molecular medicine. Oncogene 22:7070-7077.
10. Hakomori SI. 2000. Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain. Glycoconj J 17:143-151.
11. Hering H, Lin CC, Sheng M. 2003. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 23:3262-3271.
12. Igisu H, Suzuki K. 1984. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 224:753-755.
13. Iwabuchi K, Nagaoka I. 2002. Lactosylceramide-enriched glycosphingo-lipid signaling domain mediates superoxide generation from human neutrophils. Blood 100:1454-1464.
14. Iwamoto T, Fukumoto S, Kanaoka K, Sakai E, Shibata M, Fukumoto E, Inokuchi Ji J, Takamiya K, Furukawa K, Furukawa K, Kato Y, Mizuno A. 2001. Lactosylceramide is essential for the osteoclastogenesis mediated by macrophage-colony-stimulating factor and receptor activator of nuclear factor-kappa B ligand. J Biol Chem 276:46031-4608.
15. Kempermann G, Kuhn HG, Gage FH. 1997. Genetic influence on neurogenesis in the dentate gyrus of adult mice. Proc Natl Acad Sci USA 94:10409-10414.
16. Kobayashi T, Yamanaka T, Jacobs JM, Teixeira F, Suzuki K. 1980. The twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease). Brain Res 202:479-483.
17. Kolodny EH, Raghavan S, Krivit W. 1991. Late-onset Krabbe disease (globoid cell leukodystrophy): clinical and biochemical features of 15 cases. Dev Neurosci 13:232-239.
18. Kurschner VC, Petruzzi RL, Golden GT, Berrettini WH, Ferraro TN. 1998. Kainate and AMPA receptor binding in seizure-prone and seizure-resistant inbred mouse strains. Brain Res 780:1-8.
19. Kyrklund T. 1987. Two procedures to remove polar contaminants from a crude brain lipid extract by using prepacked reverse-phase columns. Lipids 22:274-277.
20. Lusa S, Blom TS, Eskelinen EL, Kuismanen E, Mansson JE, Simons K, Ikonen E. 2001. Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane. J Cell Sci 114:1893-1900.
21. Matsuda J, Vanier MT, Saito Y, Tohyama J, Suzuki K, Suzuki K. 2001a. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene causes a late-onset, slowly progressive form of globoid cell leukodystrophy in the mouse. Hum Mol Genet 10:1191-1199.
22. Matsuda J, Vanier MT, Saito Y, Suzuki K, Suzuki K. 2001b. Dramatic phenotypic improvement during pregnancy in a genetic leukodystrophy: estrogen appears to be a critical factor. Hum Mol Genet 10:2709-2715.
23. Matsumoto A, Vanier MT, Oya Y, Kelly D, Popko B, Wenger DA, Suzuki K, Suzuki K. 1997. Minimal increment in galactosylceramidase expression is sufficient for significant phenotypic improvement in twitcher mouse. Dev Brain Dysfunct 10:142-154.
24. McNamara JO. 1994. Cellular and molecular basis of epilepsy. J Neurosci 14:3413-3425.
25. Merrill Jr AH, Wang E, Mullins RE, Jamison WC, Nimkar S, Liotta DC. 1988. Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal Biochem 171:373-381.
26. Miyatake T, Suzuki K. 1972. Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase. Biochem Biophys Res Commun 48:538-543.
27. Penahian N, Yoshida T, Huang PL, Hedley-Whyte ET, Dalkara T, Fishman MC, Moskowitz MA. 1996. Attenuated hippocampal damage after global cerebral ischemia in mice mutant in neuronal nitric oxide synthase. Neuroscience 72:343-354.
28. Pollard H, Charriaut-Marlangue C, Cantagrel S, Represa A, Robain O, Moreau J, Ben-Ari Y. 1994. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience 63:7-18.
29. Sakai N, Inui K, Tatsumi N, Fukushima H, Nishigaki T, Taniike M, Nishimoto J, Tsukamoto H, Yanagihara I, Ozone K, Okada S. 1996. Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe's disease. J Neurochem 66:1118-1124.
30. Sakata-Haga H, Sawada K, Ohta K, Cui C, Hisano S, Fukui Y. 2003. Adverse effects of maternal ethanol consumption on development of dorsal hippocampus in rat offspring. Acta Neuropathol (Berl) 105:30-36.
31. Schauwecker PE, Steward O. 1997. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc Natl Acad Sci USA 94:4103-4108.
32. Seki T, Arai Y. 1993. Highly polysialylated neural cell adhesion molecule (NCAM-H) is expressed by newly generated granule cells in the dentate gyrus of the adult rat. J Neurosci 13:2351-2358.
33. Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. 1999. Characterization of a recovery global cerebral ischemia model in the mouse. J Neurosci Methods 88:103-109.
34. Shuttleworth CW, Connor JA. 2001. Strain-dependent differences in calcium signaling predict excitotoxicity in murine hippocampal neurons. J Neurosci 21:4225-4236.
35. Suzuki K. 1998. Twenty five years of the psychosine hypothesis: a personal perspective of its history and present status. Neurochem Res 23:251-259.
36. Suzuki K, Suzuki K. 1995. The twitcher mouse: a model for Krabbe disease and for experimental therapies. Brain Pathol 5:249-258.
37. Tanaka H, Suzuki K. 1976. Specificities of the two genetically distinct β-galactosidases in human sphingolipidoses. Arch Biochem Biophys 175:332-340.
38. Tohyama J, Vanier MT, Suzuki K, Ezoe T, Matsuda J, Suzuki K. 2000. Paradoxical influence of acid β-galactosidase gene dosage on phenotype of the twitcher mouse (genetic galactosylceramidase deficiency). Hum Mol Genet 9:1699-1707.
39. Toida K, Kosaka K, Heizmann CW, Kosaka T. 1996. Electron microscopic serial-sectioning/reconstruction study of parvalbumin-containing neurons in the olfactory bulb. Neuroscience 72:449-446.
40. Toida K, Kosaka K, Aika Y, Kosaka T. 2000. Chemically defined neuron groups and their subpopulations in the glomerular layer of the rat main olfactory bulb: IV. Intraglomerular synapses of tyrosine hydroxylase- immunoreactive neurons. Neuroscience 101:11-17.
41. Wenger DA, Suzuki K, Suzuki Y, Suzuki K. 2001. Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease). In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B, editors. Metabolic and molecular basis of inherited disease. New York: McGraw-Hill. p 3669-3694.